IDDI
Private Company
Funding information not available
Overview
Founded in 1991 and headquartered in Louvain-la-Neuve, Belgium, IDDI is a specialized service provider in the clinical research sector, operating as a clinical data science partner. The company leverages over 35 years of experience to offer expert biostatistics, data management, and strategic consulting services, primarily to pharmaceutical and biotechnology clients conducting clinical trials. With a strong reputation evidenced by an 80% repeat business rate from over 350 clients, IDDI supports more than 1,500 clinical trials globally. It positions itself as a premium partner ensuring data integrity and accuracy, which it views as critical because 'every data point represents a patient.'
Technology Platform
Proprietary methodologies and software for clinical data science, including the One2Treat Randomization & Trial Supply Management (RTSM) system, Electronic Data Capture (EDC), and deep expertise in CDISC data standards (SDTM, ADaM) implementation, advanced biostatistics, and regulatory strategy.
Opportunities
Risk Factors
Competitive Landscape
IDDI competes in the specialized clinical data science and biostatistics segment against both large, full-service global CROs (e.g., IQVIA, ICON, PPD) which offer similar services as part of broader packages, and smaller niche biostatistics consulting firms. Its differentiation is based on a premium, partner-focused model, deep regulatory expertise, and a strong reputation for quality.